Key result
Padua, Geneva, and Kucher models increase appropriate VTE prophylaxis but lack adequate external validation.
Why the study?
Multiple risk-assessment models (RAMs) for VTE in hospitalized medical patients have been developed, and evidence related to RAMs for VTE and bleeding was needed to inform the 2018 ASH guidelines.
Do risk-assessment models for VTE and bleeding improve outcomes or appropriate prophylaxis rates in hospitalized medical patients?
Systematic Review
Do risk-assessment models for VTE and bleeding improve outcomes or appropriate prophylaxis rates in hospitalized medical patients?
This overview of systematic reviews identified 15 VTE risk-assessment models for medical inpatients, highlighting that the Padua, Geneva, and Kucher models have demonstrated improved appropriate prophylaxis rates in impact studies.
Answers are grounded in this paper and cite their sources.
Supports use of Padua, Geneva, and Kucher models to increase appropriate prophylaxis; leaves open external validation and outcome impact.
Multiple risk-assessment models (RAMs) for venous thromboembolism (VTE) in hospitalized medical patients have been developed. To inform the 2018 American Society of Hematology (ASH) guidelines on VTE, we conducted an overview of systematic reviews to identify and summarize evidence related to RAMs for VTE and bleeding in medical inpatients. We searched Epistemonikos, the Cochrane Database, Medline, and Embase from 2005 through June 2017 and then updated the search in January 2020 to identify systematic reviews that included RAMs for VTE and bleeding in medical inpatients. We conducted study selection, data abstraction and quality assessment (using the Risk of Bias in Systematic Reviews [ROBIS] tool) independently and in duplicate. We described the characteristics of the reviews and their included studies, and compared the identified RAMs using narrative synthesis. Of 15 348 citations, we included 2 systematic reviews, of which 1 had low risk of bias. The reviews included 19 unique studies reporting on 15 RAMs. Seven of the RAMs were derived using individual patient data in which risk factors were included based on their predictive ability in a regression analysis. The other 8 RAMs were empirically developed using consensus approaches, risk factors identified from a literature review, and clinical expertise. The RAMs that have been externally validated include the Caprini, Geneva, IMPROVE, Kucher, and Padua RAMs. The Padua, Geneva, and Kucher RAMs have been evaluated in impact studies that reported an increase in appropriate VTE prophylaxis rates. Our findings informed the ASH guidelines. They also aim to guide health care practitioners in their decision-making processes regarding appropriate individual prophylactic management.
No takes yet. Share an insight, caveat, or question.
Darzi et al. (2020) conducted a systematic review in Venous thromboembolism (VTE) and bleeding. Risk-assessment models (RAMs) vs. Standard care or alternative RAMs was evaluated on Predictive performance and impact on VTE prophylaxis rates. The Padua, Geneva, and Kucher risk-assessment models for venous thromboembolism increased appropriate prophylaxis rates in hospitalized medical patients, although most models lack adequate external validation.
Synapse has enriched 10 related papers. Consider them for comparative context: